About
Blacksmith Medicines develops therapeutics by targeting human metalloenzymes with a proprietary platform to create novel treatments for immuno-oncology and inflammatory diseases.
Explore Blacksmith Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.